Myxoma Virus Expressing a Fusion Protein of Interleukin-15 (IL15) and IL15 Receptor Alpha Has Enhanced Antitumor Activity
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Myxoma Virus Expressing a Fusion Protein of Interleukin-15 (IL15) and IL15 Receptor Alpha Has Enhanced Antitumor Activity
Authors
Keywords
-
Journal
PLoS One
Volume 9, Issue 10, Pages e109801
Publisher
Public Library of Science (PLoS)
Online
2014-10-21
DOI
10.1371/journal.pone.0109801
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of Tumor Growth by NK1.1+ Cells and CD8+ T Cells Activated by IL-15 through Receptor /Common Signaling in trans
- (2014) J. Rowley et al. JOURNAL OF IMMUNOLOGY
- Preassociation of IL-15 with IL-15R -IgG1-Fc Enhances Its Activity on Proliferation of NK and CD8+/CD44high T Cells and Its Antitumor Action
- (2014) S. Dubois et al. JOURNAL OF IMMUNOLOGY
- Efficacy and Mechanism-of-Action of a Novel Superagonist Interleukin-15: Interleukin-15 Receptor Su/Fc Fusion Complex in Syngeneic Murine Models of Multiple Myeloma
- (2013) W. Xu et al. CANCER RESEARCH
- Oncolytic myxoma virus: The path to clinic
- (2013) Winnie M. Chan et al. VACCINE
- Regulation of Mouse NK Cell Development and Function by Cytokines
- (2013) Antoine Marçais et al. Frontiers in Immunology
- Selective Purging of Human Multiple Myeloma Cells from Autologous Stem Cell Transplantation Grafts using Oncolytic Myxoma Virus
- (2012) Eric Bartee et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Design and characterization of a protein superagonist of IL-15 fused with IL-15Rα and a high-affinity T cell receptor
- (2012) Jennifer D. Stone et al. BIOTECHNOLOGY PROGRESS
- Densely Granulated Murine NK Cells Eradicate Large Solid Tumors
- (2012) R. B. Liu et al. CANCER RESEARCH
- Regulating the immune system via IL-15 transpresentation
- (2012) Eliseo F. Castillo et al. CYTOKINE
- An Antibody Fusion Protein for Cancer Immunotherapy Mimicking IL-15 trans -Presentation at the Tumor Site
- (2012) Vanessa Kermer et al. MOLECULAR CANCER THERAPEUTICS
- Myxoma Virus Sensitizes Cancer Cells to Gemcitabine and Is an Effective Oncolytic Virotherapeutic in Models of Disseminated Pancreatic Cancer
- (2012) Sonia Tusell Wennier et al. MOLECULAR THERAPY
- Oncolytic virotherapy
- (2012) Stephen J Russell et al. NATURE BIOTECHNOLOGY
- Recombinant viral vaccines for cancer
- (2012) Ryan Cawood et al. TRENDS IN MOLECULAR MEDICINE
- Expressing human interleukin-15 from oncolytic vesicular stomatitis virus improves survival in a murine metastatic colon adenocarcinoma model through the enhancement of anti-tumor immunity
- (2011) K B Stephenson et al. CANCER GENE THERAPY
- Myxoma virus combined with rapamycin treatment enhances adoptive T cell therapy for murine melanoma brain tumors
- (2011) Diana L. Thomas et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Interleukin 15 as a promising candidate for tumor immunotherapy
- (2011) Marek Jakobisiak et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Interleukin-15 biology and its therapeutic implications in cancer
- (2011) Jason C. Steel et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Myxoma Virus Virotherapy for Glioma in Immunocompetent Animal Models: Optimizing Administration Routes and Synergy with Rapamycin
- (2010) X. Lun et al. CANCER RESEARCH
- Oncolytic viral purging of leukemic hematopoietic stem and progenitor cells with Myxoma virus
- (2010) Masmudur M. Rahman et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Efficacy and Safety/Toxicity Study of Recombinant Vaccinia Virus JX-594 in Two Immunocompetent Animal Models of Glioma
- (2010) XueQing Lun et al. MOLECULAR THERAPY
- Mature natural killer cells with phenotypic and functional alterations accumulate upon sustained stimulation with IL-15/IL-15R complexes
- (2010) K. G. Elpek et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor–Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma
- (2009) Neil N. Senzer et al. JOURNAL OF CLINICAL ONCOLOGY
- Myxoma Virus Expressing Interleukin-15 Fails To Cause Lethal Myxomatosis in European Rabbits
- (2009) J. Liu et al. JOURNAL OF VIROLOGY
- High antitumor activity of RLI, an interleukin-15 (IL-15)-IL-15 receptor fusion protein, in metastatic melanoma and colorectal cancer
- (2009) A. Bessard et al. MOLECULAR CANCER THERAPEUTICS
- Interleukin-15/Interleukin-15R Complexes Promote Destruction of Established Tumors by Reviving Tumor-Resident CD8+ T Cells
- (2008) M. Epardaud et al. CANCER RESEARCH
- Oncolytic Efficacy of Recombinant Vesicular Stomatitis Virus and Myxoma Virus in Experimental Models of Rhabdoid Tumors
- (2008) Y. Wu et al. CLINICAL CANCER RESEARCH
- Twelve immunotherapy drugs that could cure cancers
- (2008) Martin A. ‘Mac’ Cheever IMMUNOLOGICAL REVIEWS
- The Exon-3-Encoded Domain of IL-15Rα Contributes to IL-15 High-Affinity Binding and Is Crucial for the IL-15 Antagonistic Effect of Soluble IL-15Rα
- (2008) Grégory Bouchaud et al. JOURNAL OF MOLECULAR BIOLOGY
- Myxoma Virus Oncolysis of Primary and Metastatic B16F10 Mouse Tumors In Vivo
- (2007) Marianne M Stanford et al. MOLECULAR THERAPY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now